Radiation therapy is a local treatment, meaning that it affects only the area of the body being treated. In people who are treated to the head and neck area, side effects include mouth sores and a sore throat. In those who undergo radiation therapy to the gastrointestinal tract, side effects can include nausea, diarrhea, and inflammation of the esophagus, the tube that connects the mouth to the stomach.
The good news is that by being proactive with their diets, people who undergo radiation therapy can favorably influence their quality of life. According to Dr. Kornmehl, a board certified radiation oncologist at St. Mary's Passaic Hospital, Passaic, NJ and author of the critically acclaimed consumer health book, “The Best News About Radiation Therapy,” a registered dietician should screen all screens radiation therapy patients. The dietician will evaluate the person’s baseline nutritional status and will then implement dietary intervention prior to the person’s initiating radiation therapy.
Want more information go to RTSupportDoc.com at www.RTSupportDoc.com.
This website is dedicated to helping people undergoing radiation therapy, where you'll learn more about cancer, radiation therapy and can sign up for a monthly newsletter.
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...